PURPOSE To learn more about the effectiveness of oral propranolol as a therapeutic
alternative for preterm newborns with pre-existing retinopathy of prematurity (ROP) as well …

El hemangioma infantil es un tumor vascular benigno, el más frecuente de la infancia, cuya
evolución natural favorece la desaparición de la lesión en la misma edad pediátrica y que …

Infantile haemangioma (IH) remains the most common benign vascular tumour in childhood.
Although most IH can be managed conservatively, a proportion of these lesions can cause …

Infantile hemangioma is the most frequent benign vascular tumor in childhood, with an
incidence of 3 to 10%. When patients require treatment, oral propranolol, a non-selective …

Infantile hemangioma (IH) is the most common benign tumor of infancy. For children with IH
who require treatment, propranolol and other beta blockers have been shown to be safe and …

Background: Despite the excellent clinical efficacy of oral propranolol in the management of
infantile haemangiomas (IHs), there is a need to further evaluate other beta blockers that …

Beta adrenergic antagonists and antianginal drugs are used with the aim to decrease
mortality and enable patients to lead an improved quality of life by avoidance of anginal …

Infantile Hemangioma (IH) affects around 5% of infants, it is the most common tumor during
childhood. 1, 2 At birth, lesions are usually imperceptible and develop through an early …

Introducción El hemangioma infantil corresponde al tumor vascular benigno más frecuente
de la infancia, con una incidencia de 3 a 10%. Entre los pacientes que requieren …

Introduction Infantile hemangioma is the most frequent benign vascular tumor in childhood,
with an incidence of 3 to 10%. When patients require treatment, oral propranolol, a non …